Our Webinars

Optimizing Clinical Trials Using Adaptive Design: Early Alignment for Success

Optimizing Clinical Trials Using Adaptive Design: Early Alignment for Success

Date: Thursday, July 2, 2020
Time: 11am EDT(NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
Length: 60 minutes

REGISTER

Adaptive designs are a wide umbrella for any design which changes during a trial, but in a pre-specified manner. They may allow for earlier go/no-go decisions and the ability to potentially answer more questions than traditional drug development. For example, testing additional small population subgroups (or tumor types) to be included in a basket trial could result in the approval in any or all groups when those smaller populations may have been excluded in a standard trial. Adaptive designs could include the use of a historical control, borrowing across treatment arms and/or tumor types, adjusting the sample size during the trial, dropping unfavorable arms and/or stopping early due to effectiveness.

Adaptive designs used to have a stigma with some designs, even being considered not “well-understood.” However, regulatory agencies and drug developers are starting to see what fruits these designs may bear, as examples of success include master protocols/platform/umbrella trials, the PREVAIL II Ebola trial and other published studies. These results of interaction with the FDA through the Complex Innovative Design program have become available to the public.

This webinar will provide a deep dive into what questions drug developers can ask themselves to determine whether their development plan is a candidate for incorporating some aspects of an adaptive design and if the plan may be better suited to an early or late phase adaptive design. It will offer an expanded understanding of exactly what it means to run an adaptive trial.

Speaker:

  • Christopher Tait, PhD, Senior Biostatistician, Synteract


Looking for a previous webinar? Go to our Webinars Archive arrow
x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract General Medicince Clinical Trial Leadership

Linda RawlingsContact us to find out more about our General Medicine expertise and experience

Linda Rawlings, MSc, FIBMS
VP General Medicine

Contact us to find out more about our General Medicine expertise and experience
x

Synteract Rare, Orphan, & Pediatric Diseases Clinical Trial Leadership

Lisa DilworthContact us to find out more about our Pediatric and Rare and Orphan Diseases expertise and experience

Lisa Dilworth
VP, Strategic Development, Rare, Orphan and Pediatric Diseases

Contact us to find out more about our Rare, Orphan, & Pediatric Diseases expertise and experience
x

 

x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required